Microcapsules made by enzymatically tailored alginate

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Biotechnology

Background:

• Alginate is a versatile polysaccharide widely used for cell encapsulation.
• C-5 epimerase enzymes can modify alginate structure, altering its properties.
• AlgE4 specifically creates alternating mannuronic acid (M) and guluronic acid (G) blocks.

Purpose of the Study:

• To investigate the impact of AlgE4-epimerized alginate on capsule stability and permeability.
• To evaluate the performance of modified alginates in different capsule formulations.
• To understand the interaction of alternating alginate structures with capsule components.

Main Methods:

• Preparation of inhomogeneous calcium-alginate gel beads using original and epimerized alginates.
• Measurement of capsule permeability using immunoglobulin (Ig) G diffusion.
• Assessment of osmotic swelling resistance and osmotic stability.
• Fabrication of alginate-poly-D-lysine(PDL)-alginate capsules and evaluation of permeability to tumor necrosis factor (TNF).

Main Results:

• Epimerized alginates formed smaller gels with increased resistance to osmotic swelling.
• Capsule permeability to IgG was reduced by epimerization and further decreased with poly-L-lysine (PLL) addition.
• Alginate-PDL-alginate capsules showed enhanced osmotic stability and low TNF permeability with epimerized alginate.
• Alternating alginate structures exhibited stronger interaction with alginate-PLL capsules compared to M-rich or G-rich alginates.

Conclusions:

• AlgE4-epimerized alginates offer superior properties for creating stable and low-permeability capsules.
• Tailoring alginate structure through epimerization provides a method to enhance biomaterial performance.
• The alternating M/G structure is key to improved capsule integrity and controlled diffusion.